133 related articles for article (PubMed ID: 21172894)
1. Inclusion of tumor biology molecular markers to improve the ductal carcinoma in situ ipsilateral breast tumor recurrence nomogram predictability.
Ballehaninna UK; Chamberlain RS
J Clin Oncol; 2011 Feb; 29(4):e97-8; author reply e99. PubMed ID: 21172894
[No Abstract] [Full Text] [Related]
2. Nomogram for risk of relapse after breast-conserving surgery in ductal carcinoma in situ.
Mazouni C; Delaloge S; Rimareix F; Garbay JR
J Clin Oncol; 2011 Jan; 29(2):e44; author reply e45-6. PubMed ID: 21135281
[No Abstract] [Full Text] [Related]
3. [The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999].
Schwartz GF; Solin LJ; Olivotto IA; Ernster VL;
Bull Cancer; 2000 Jun; 87(6):499-506. PubMed ID: 10903791
[No Abstract] [Full Text] [Related]
4. DCIS prognostic markers: a few new candidates emerge.
Nelson NJ
J Natl Cancer Inst; 2010 May; 102(9):588-90. PubMed ID: 20427428
[No Abstract] [Full Text] [Related]
5. Can some DCIS patients avoid adjuvant therapy? Still unknown.
Schmidt C
J Natl Cancer Inst; 2011 Apr; 103(7):530-1. PubMed ID: 21436062
[No Abstract] [Full Text] [Related]
6. Ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ.
Fujita T
Ann Surg; 2011 Jun; 253(6):1233; author reply 1233-4. PubMed ID: 21522008
[No Abstract] [Full Text] [Related]
7. Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy.
Weaver DL
Cancer; 2003 Nov; 98(10):2083-7. PubMed ID: 14601075
[No Abstract] [Full Text] [Related]
8. Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?
Solin LJ
J Clin Oncol; 2006 Mar; 24(7):1017-9. PubMed ID: 16461780
[No Abstract] [Full Text] [Related]
9. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
[TBL] [Abstract][Full Text] [Related]
10. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Rudloff U; Jacks LM; Goldberg JI; Wynveen CA; Brogi E; Patil S; Van Zee KJ
J Clin Oncol; 2010 Aug; 28(23):3762-9. PubMed ID: 20625132
[TBL] [Abstract][Full Text] [Related]
11. Validation of a nomogram for predicting risk of local recurrence for ductal carcinoma in situ.
Van Zee KJ; Patil S
J Clin Oncol; 2012 Sep; 30(25):3143-4; author reply 3144-5. PubMed ID: 22826276
[No Abstract] [Full Text] [Related]
12. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of wide excision alone for ductal carcinoma in situ of the breast.
Lagios MD; Page DL; Silverstein MJ
J Clin Oncol; 2006 Aug; 24(23):3809-11; author reply 3811-2. PubMed ID: 16896011
[No Abstract] [Full Text] [Related]
14. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
15. Random physician effect and comparative effectiveness of treatment for ductal carcinoma in situ.
Virnig BA; Tuttle TM
J Natl Cancer Inst; 2011 Jan; 103(2):81-2. PubMed ID: 21200026
[No Abstract] [Full Text] [Related]
16. The effect of margins on the clinical management of ductal carcinoma in situ of the breast.
Meijnen P; Gilhuijs KG; Rutgers EJ
J Surg Oncol; 2008 Dec; 98(8):579-84. PubMed ID: 19072848
[TBL] [Abstract][Full Text] [Related]
17. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?
von Smitten K
J Surg Oncol; 2008 Dec; 98(8):585-7. PubMed ID: 19072849
[TBL] [Abstract][Full Text] [Related]
18. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
Finkelstein SD; Sayegh R; Thompson WR
Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
[TBL] [Abstract][Full Text] [Related]
19. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.
MacDonald HR; Silverstein MJ; Mabry H; Moorthy B; Ye W; Epstein MS; Holmes D; Silberman H; Lagios M
Am J Surg; 2005 Oct; 190(4):521-5. PubMed ID: 16164913
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ: dilemma or denouement.
Lagios MD; Silverstein MJ
J Clin Oncol; 2010 May; 28(14):e218-9; author reply e220. PubMed ID: 20368539
[No Abstract] [Full Text] [Related]
[Next] [New Search]
